Back

Gain-of-function assay for SARS-CoV-2 Mpro inhibition in living cells

Moghadasi, S. A.; Becker, J. T.; Belica, C.; Wick, C.; Brown, W. L.; Harris, R.

2020-11-09 microbiology
10.1101/2020.11.09.375139 bioRxiv
Show abstract

The main protease, Mpro, of SARS-CoV-2 is required to cleave the viral polyprotein into precise functional units for virus replication and pathogenesis. Here we demonstrate a quantitative reporter for Mpro function in living cells, in which protease inhibition by genetic or chemical methods results in strong eGFP fluorescence. This robust gain-of-function system readily distinguishes between inhibitor potencies and can be scaled-up to high-throughput platforms for drug testing.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.